News & Updates

Our past conferences have been full of valuable information and great networking opportunities. We expect this year to be the same. Welcome to our 4th Global IDMP Working Group (GIDWG) Stakeholder Meeting, planned for the third week of September 2024, hosted by the Brazilian Health Regulatory Agency (Anvisa) in Brazil.

UPDATE: Thank you to everyone who attended the 4th GIDWG Technical and Stakeholder Meeting for making it such a success. It provided an excellent platform to further our shared vision of global IDMP implementation.

Presentations materials:

Testing of use cases for PhPID operating model

PURPOSE

To test the framework, including business rules, best practices, software, and operating model, for global IDMP implementation and maintenance of global identifiers for marketed products.

SCOPE

• Validate and generate PhPIDs for medicinal products based on GIDWG/EWG Business Rules

• EDQM and non-EDQM countries

• Similar products from different countries

• Larger batches and smaller data sets for regulators  

• Test use cases for pharmacovigilance, drug shortages, and cross-border healthcare

STATUS

Completed

Global IDMP PhPID End-to-End Testing report, 5 December 2024

The IDMP standards aim to harmonise how pharmaceutical products and substances are described globally. But how will that benefit patients and who will make sure the standards are properly implemented? Uppsala Monitoring Centre’s Malin Fladvad and Olle Lagerlund discuss the advantages and challenges of this global standardisation effort in the Drug Safety Matters podcast.